CRP and non-small cell lung carcinoma: Therefore, Forrest and colleagues first (52) proposed the Glasgow Prognostic Score (GPS) in combination of CRP and serum albumin, and confirmed its prognostic value in NSCLC, particularly when considering the clinical stage.